Nicht mehr anzeigen

Investiere dein Geld nicht in Gebühren.Wechsle jetzt zum Kostensieger!

Standard-Ordergebühren / 10 Trades*

Consorsbank

112,00 € (zzgl. Spreads)

ING

111,50 € (zzgl. Spreads)

comdirect

111,50 € (zzgl. Spreads)

finanzen.net ZERO

Kostensieger (Stiftung Warentest 12/2025)

ab 0,00 € (zzgl. Spreads)

Jetzt informieren

Kostenlose Depotführung. Papierlose Eröffnung.

* 10 Trades à 2.500 € am günstigsten Handelsplatz für den Handel mit DAX-Aktien. Quelle: Online-Broker-Vergleich 09/2026

NEU: bis zu 240 € Cashback!

EQS-NVR: Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18.10.23 14:53 Uhr

EQS Total Voting Rights Announcement: Epigenomics AG / Total Voting Rights Announcement
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18.10.2023 / 14:53 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Publication of total number of voting rights

1. Details of issuer

Epigenomics AG
Bertha-Benz-Straße 5
10557 Berlin
Germany

2. Type of capital measure

	Type of capital measure	Date of status / date of effect
X	Conditional capital increase (Sec. 41 para. 2 WpHG)	18.10.2023
	Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:

4267087

18.10.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com